{
    "organizations": [],
    "uuid": "bb6545d2de832f347e784b7f85e85fedd6a27073",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-synairgen-says-patients-been-dosed/brief-synairgen-says-patients-been-dosed-in-phase-ii-trial-of-inhaled-sng001-idUSFWN1PX026",
    "ord_in_thread": 0,
    "title": "BRIEF-Synairgen Says Patients Been Dosed In Phase II Trial Of Inhaled Sng001",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Synairgen Plc:\n* ‍FIRST PATIENTS BEEN DOSED IN COMPANY‘S PHASE II TRIAL OF INHALED SNG001 IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-02-07T15:20:00.000+02:00",
    "crawled": "2018-02-09T05:39:49.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "synairgen",
        "plc",
        "patient",
        "dosed",
        "company",
        "phase",
        "ii",
        "trial",
        "inhaled",
        "sng001",
        "patient",
        "chronic",
        "obstructive",
        "pulmonary",
        "disease",
        "copd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}